Bath & Body Works, Inc. $BBWI Position Decreased by Forest Avenue Capital Management LP

Forest Avenue Capital Management LP lessened its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 18.7% during the 1st quarter, HoldingsChannel reports. The fund owned 1,660,961 shares of the company’s stock after selling 383,230 shares during the quarter. Bath & Body Works comprises approximately 6.8% of Forest Avenue Capital Management LP’s portfolio, making the stock its 9th biggest holding. Forest Avenue Capital Management LP’s holdings in Bath & Body Works were worth $50,360,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also modified their holdings of BBWI. Victory Capital Management Inc. boosted its stake in shares of Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company’s stock worth $206,119,000 after acquiring an additional 6,752,274 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its position in shares of Bath & Body Works by 115.7% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock valued at $111,581,000 after purchasing an additional 1,973,679 shares during the period. Assenagon Asset Management S.A. raised its position in shares of Bath & Body Works by 3,642.2% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company’s stock valued at $50,062,000 after purchasing an additional 1,606,988 shares during the period. Interval Partners LP bought a new stake in shares of Bath & Body Works during the 4th quarter valued at $37,992,000. Finally, BNP Paribas Financial Markets bought a new stake in shares of Bath & Body Works during the 4th quarter valued at $36,445,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Up 5.6%

Bath & Body Works stock opened at $31.0550 on Friday. The company’s 50-day moving average price is $30.30 and its 200-day moving average price is $31.03. Bath & Body Works, Inc. has a twelve month low of $24.94 and a twelve month high of $41.87. The company has a market cap of $6.57 billion, a PE ratio of 8.28, a price-to-earnings-growth ratio of 0.99 and a beta of 1.54.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.02. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The firm had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same period in the previous year, the firm posted $0.38 EPS. The business’s quarterly revenue was up 2.9% on a year-over-year basis. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. As a group, sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Stockholders of record on Friday, August 22nd will be issued a $0.20 dividend. The ex-dividend date is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.6%. Bath & Body Works’s payout ratio is 21.33%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on BBWI shares. JPMorgan Chase & Co. raised their price objective on shares of Bath & Body Works from $40.00 to $46.00 and gave the company an “overweight” rating in a research report on Monday, July 28th. Piper Sandler set a $39.00 price objective on shares of Bath & Body Works and gave the company an “overweight” rating in a research report on Thursday, May 15th. Morgan Stanley decreased their price objective on shares of Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 6th. The Goldman Sachs Group reduced their price target on shares of Bath & Body Works from $44.00 to $43.00 and set a “buy” rating on the stock in a report on Friday, May 30th. Finally, Wall Street Zen downgraded shares of Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $42.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.